ALLISON LUEDEKER: Open Payments
NPI 1457828683 · STEPHENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 22 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Abbott Laboratories | 2 | $42 |
| Exact Sciences Corporation | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| Eisai Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| TOLMAR, INC. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: Ozempic, AIRSUPRA, FREESTYLE LIBRE, The Cologuard Plus Collection Kit, Leqembi, TRELEGY ELLIPTA, JATENZO, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
